First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel–Lindau disease to advanced renal cell carcinoma

Cancer Chemotherapy and Pharmacology 2026

View at publisher

Authors: Irem Karaman, Dilek Gurgenyatagi Erdem, Bülent Çetin

DOI: 10.1007/s00280-025-04861-x

Cited by: 1

References: 52

Fields of Study & Subjects

Cancer Hypoxia and Metabolism Renal cell carcinoma treatment Adrenal and Paraganglionic Tumors

References 52